Vitality Biopharma Inc. (VBIO)
Stock Price: $0.1770 USD
0.0070 (4.12%)
Updated Jun 14, 2021 2:26 PM EDT - Market closed
| Market Cap | 7.63M |
| Revenue (ttm) | 258,288 |
| Net Income (ttm) | -880,851 |
| Shares Out | 50.84M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 14 |
| Last Price | $0.1770 |
| Previous Close | $0.1700 |
| Change ($) | 0.0070 |
| Change (%) | 4.12% |
| Day's Open | 0.1851 |
| Day's Range | 0.1700 - 0.1900 |
| Day's Volume | 47,033 |
| 52-Week Range | 0.0500 - 0.5500 |
News
There are no news available yet.
About VBIO
Vitality Biopharma, Inc. focuses on developing cannabinoid pharmaceutical prodrugs in the United States. The company produces approximately 25 novel cannabosides, including glycosylated tetrahydrocannabinol (THC), cannabidiol, cannabidivarin, and cannabinol. It is developing THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vi... [Read more...]
| Industry Biotechnology | Founded 2007 |
| Stock Exchange OTCMKTS | Ticker Symbol VBIO |